Opko Health OPK
NASDAQ OPK
$1.73 +0.03 (+2.07%)
As of: Sep 22, 2026 · 11:37 AM EDT

Opko Health (OPK) Depreciation & Amortization (CF) (2010 - 2026)

Opko Health's (OPK) quarterly Depreciation & Amortization (CF) came in at $22.4 million in Q2 2026, down 2.68% on a YoY basis from $23.0 million in Q2 2025, and up 0.94% quarter-over-quarter from $22.2 million in Q1 2026.

Analysis

Opko Health (OPK) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $22.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 2.68% year-over-year to $22.4 million; the trailing twelve-month figure through Jun 2026 stood at $89.7 million (down 25.64% YoY), and the FY2025 full-year result was $91.6 million, down 6.67% from the prior year.
  • Depreciation & Amortization (CF) grew to $22.4 million in Q2 2026 per OPK's latest filing, from $22.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $74.1 million in Q3 2024 and bottomed at $22.2 million in Q1 2026.
  • Historically, Depreciation & Amortization (CF) has averaged $29.5 million across 5 years, with a median of $26.2 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) surged 183.15% in 2024, then plunged 69.33% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $26.5 million in 2022, then declined by 1.81% to $26.0 million in 2023, then soared by 185.34% to $74.1 million in 2024, then sank by 69.82% to $22.4 million in 2025, then climbed by 0.16% to $22.4 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $22.4 million, $22.2 million, and $22.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 1.96 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 1.62 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 594.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 3.97 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 40.52 Mn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn 22.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.41 Mn
Mar 31, 2026 22.20 Mn
Dec 31, 2025 22.37 Mn
Sep 30, 2025 22.74 Mn
Jun 30, 2025 23.03 Mn
Mar 31, 2025 23.49 Mn
Sep 30, 2024 74.14 Mn
Jun 30, 2024 49.97 Mn
Mar 31, 2024 25.82 Mn
Dec 31, 2023 25.98 Mn
Sep 30, 2023 26.18 Mn
Jun 30, 2023 26.39 Mn
Mar 31, 2023 26.45 Mn
Dec 31, 2022 26.46 Mn
Sep 30, 2022 28.00 Mn
Jun 30, 2022 28.00 Mn
Mar 31, 2022 27.81 Mn
Dec 31, 2021 19.19 Mn
Sep 30, 2021 18.96 Mn
Jun 30, 2021 20.57 Mn
API Access

Opko Health Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OPK&period=max&api_key=YOUR_API_KEY